特一药业：2025年半年度净利润约3801万元，同比增加1313.23%

Core Insights - The company reported a significant increase in revenue and net profit for the first half of 2025, indicating strong financial performance [2] Financial Performance - The company's operating revenue for the first half of 2025 was approximately 491 million yuan, representing a year-on-year increase of 56.54% [2] - The net profit attributable to shareholders was around 38.01 million yuan, showing a substantial year-on-year increase of 1313.23% [2] - Basic earnings per share reached 0.08 yuan, which is a year-on-year increase of 1500% [2]